Calidi Biotherapeutics Inc Share Price

NYSE: CLDI

Small Cap

$1.58

-0.02

(-0.94%)

as on September 18, 2025 at 1:28 am IST

$₹

Calidi Biotherapeutics Inc Stock Performance

as on September 18, 2025 at 1:28 am IST

Day's Low
Day's High
$1.57
Day's Price Range
$1.61
$1.58
0.63%
Downside
1.90%
Upside
52 Week's Low
52 Week's High
$1.51
52-Week Price Range
$46.68
$1.58
4.43%
Downside
2854.43%
Upside

Calidi Biotherapeutics Inc share price movements today

Previous Close: $1.60
Open: $1.61
Volume: 269.6K
Day's Low - High: $1.57 - $1.61
52 Week Low - High: $1.51 - $46.68

Calidi Biotherapeutics Inc Historical Returns

1 Month Return: -69.81 %
3 Month Return: -56.99 %
1 Year Return: -88.58 %
3 Year Return: 0 %
5 Year Return: 0 %

Calidi Biotherapeutics Inc Stock Fundamentals & Key Indicators

Check Calidi Biotherapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$8.6M

EPS (TTM)

-5.4002

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-19.5M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

8373400.00%

Calidi Biotherapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Calidi Biotherapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Calidi Biotherapeutics Inc	BUY	$8.6M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	252.04%	-505.15	-12.96%
Beone Medicines Ltd	NA	$39.0B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$100.3B	44.17%	27.85	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	1.78%	14.1	31.37%

Stock Returns calculator for Calidi Biotherapeutics Inc Stock including INR - Dollar returns

The Calidi Biotherapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Calidi Biotherapeutics Inc investment value today

Current value as on today

₹15,868

Returns

₹84,132

(-84.13%)

Returns from Calidi Biotherapeutics Inc Stock

₹88,730 (-88.73%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Calidi Biotherapeutics Inc Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Calidi Biotherapeutics Inc. Average target price of $120

Calidi Biotherapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Calidi Biotherapeutics Inc.

What analysts predicted

98.68%UPSIDE

Target Price

$120

Current Price

$1.58

Analyzed by

8 Analysts

Target

$120.00

Calidi Biotherapeutics Inc target price $120, a slight upside of 98.68% compared to current price of $1.58. According to 8 analysts rating.

Calidi Biotherapeutics Inc Stock's Interest Amongst Investors

Investment in Calidi Biotherapeutics Inc Shares on INDmoney has dropped by -28.66% over the past 30 days, indicating reduced transactional activity.

Time period: August 19, 2025 to September 18, 2025

Change:-28.66% versus previous 30 day period

Search interest for Calidi Biotherapeutics Inc Stock has decreased by -30% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:-30% versus previous 30 day period

Calidi Biotherapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	-	-	1	-	-
Gross Profit	-	-	0	0	0	0	0	0	0	0
Operating Income	-2	-1	-7	-9	-6	-5	-5	-4	-5	-5
EBITDA	-5	-1	-1	-7	-6	-5	-4	-3	-4	-5
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-2	-4	-2	-8	-7	-5	-5	-4	-5	-5
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-6	-12	-2	-8	-7	-5	-5	-4	-4	-5
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-272.41%	0.00%	0.00%

Calidi Biotherapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	0	0	-	-
Gross Profit	-	0	0	-1	-1
Operating Income	-6	-10	-23	-28	-21
EBITDA	-6	-9	-24	-24	-21
Interest Expense	0	0	0	3	0
Depreciation	0	0	0	1	1
Income Before Tax	-7	-10	-25	-29	-22
Income Tax Expense	0	0	0	0	0
Net Income	-7	-10	-25	-29	-22
Net Profit Margin	0.00%	-2434.97%	-56504.44%	0.00%	0.00%

Calidi Biotherapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-4	-2	-8	-7	-7	-5	-4	-4	-5
Operating Cash Flow	0	-22	-5	-3	-3	-4	-5	-7	-4
Investing Cash Flow	0	0	0	-	0	-	-	-	-
Financing Cash Flow	0	31	-2	3	3	6	13	8	0
Change in Cash	0	9	-8	0	0	1	7	0	-5

Calidi Biotherapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-10	-25	-29	-22
Operating Cash Flow	-7	-13	-26	-19
Investing Cash Flow	0	0	0	0
Financing Cash Flow	9	12	29	27
Change in Cash	1	-1	1	7

Insights on Calidi Biotherapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.1% return, outperforming this stock by 156.7%
NEGATIVE IMPACT
Price Dip
In the last 1 month, CLDI stock has moved down by -69.8%

About Calidi Biotherapeutics Inc

Calidi Biotherapeutics, Inc. is a clinical-stage immuno-oncology company. The Company is developing proprietary allogeneic stem cell-based and enveloped virus platforms to potentiate and deliver oncolytic viruses (vaccinia virus and adenovirus) and, potentially, other molecules to cancer patients. It is focused on developing two proprietary stem cell-based platforms and one enveloped vaccinia virus platform designed to protect the oncolytic virus, whether natural or engineered, from neutralization by the patient’s immune defenses, allowing for greater infection of the tumor cells and leading to a potential improvement in the antitumor activity of oncolytic viruses over traditional naked oncolytic virus therapies. Its product candidates include the CLD-101 product for high grade glioma (HGG), CLD-101 product for Recurrent HGG, CLD-201 product for solid tumors, CLD-301 (AAA) for multiple indications and CLD-400 (RTNova) for certain lung cancer and metastatic solid tumors.

Organisation	Calidi Biotherapeutics Inc
Headquarters	4475 Executive Drive, San Diego, CA, United States, 92121
CEO	Dr. Eric E. Poma Ph.D.
E-voting on shares	Click here to vote

Key Management of Calidi Biotherapeutics Inc

Name	Title
Mr. Andrew C. Jackson	Chief Financial Officer
Ms. Wendy Pizarro Campbell Esq.	Chief Legal, Chief Corporate Dev, Chief Diversity & Corp Sec.
Dr. Eric E. Poma Ph.D.	CEO & Director
Dr. Antonio Fernandez Santidrian Ph.D., Pharm.D.	Head of Technical Operations & Chief Scientific Officer
Dr. Guy Travis Clifton M.D.	Chief Medical Officer, Consultant & Advisor

FAQs

What is Calidi Biotherapeutics Inc share price today?

Calidi Biotherapeutics Inc share price today is $1.58 as on September 18, 2025 at 1:28 am IST at the close of the market. Calidi Biotherapeutics Inc share today touched a day high of $1.61 and a low of $1.57.

What is the 52 week high and 52 week low for Calidi Biotherapeutics Inc share?

Calidi Biotherapeutics Inc share touched a 52 week high of $46.68 on November 13, 2024 and a 52 week low of $1.51 on September 4, 2025. Calidi Biotherapeutics Inc stock price today i.e. September 18, 2025 at 1:28 am IST is closed at $1.58,which is 96.62% down from its 52 week high and 4.64% up from its 52 week low.

What is Calidi Biotherapeutics Inc's market capitalisation today?

Calidi Biotherapeutics Inc market capitalisation is $0.00T as on September 18, 2025 at 1:28 am IST.

How to invest in Calidi Biotherapeutics Inc Stock (CLDI) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Calidi Biotherapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Calidi Biotherapeutics Inc Shares that will get you 0.9494 shares as per Calidi Biotherapeutics Inc share price of $1.58 per share as on September 18, 2025 at 1:28 am IST.

What is the minimum amount required to buy Calidi Biotherapeutics Inc Stock (CLDI) from India?

Indian investors can start investing in Calidi Biotherapeutics Inc (CLDI) shares with as little as ₹87.816 or $1 (as of September 18, 2025 at 4:38 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Calidi Biotherapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 4:38 am IST). Based on Calidi Biotherapeutics Inc share’s latest price of $1.58 as on September 18, 2025 at 1:28 am IST, you will get 6.3291 shares of Calidi Biotherapeutics Inc. Learn more about fractional shares .